New England Biolabs

New England Biolabs (NEB) is a leading provider of essential reagents for the life sciences industry, renowned for its commitment to innovation and quality. Established in 1974, NEB has been at the forefront of molecular biology research, offering a wide range of products that support genomic research and biotechnology applications.

The company specializes in the development and manufacture of enzymes, reagents, and kits that are crucial for DNA and RNA manipulation. Their extensive product portfolio includes restriction enzymes, DNA polymerases, and cloning kits, which are widely used by researchers around the globe.

NEB is dedicated to advancing scientific discovery through its robust research and development initiatives. The company invests significantly in new technologies and methodologies, ensuring that it remains a trusted partner for scientists in academia and industry.

With a strong emphasis on customer support, NEB provides comprehensive resources, including technical assistance and educational materials, to help researchers achieve their goals. The company also fosters collaboration with academic institutions and research organisations to drive innovation in the field.

NEB’s vision is to empower scientists to make groundbreaking discoveries that improve human health and the environment. By prioritising sustainability and ethical practices, NEB aims to contribute positively to the global community.

Headquartered in Ipswich, Massachusetts, NEB operates globally, with a presence in over 100 countries. The company is committed to maintaining high standards of quality and compliance, ensuring that all products meet rigorous regulatory requirements.

In summary, New England Biolabs stands as a pillar of support for the scientific community, providing high-quality products and services that facilitate research and innovation in molecular biology.